Clinical Trial

Effects of Hemp-Derived Cannabinoids on Menopause Symptoms

Name: Effects of Hemp-Derived Cannabinoids on Menopause Symptoms — clinical trial record (NCT07393672)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-30.

Status change: Not Yet Recruiting → Recruiting 2026-03-06

Trial Details

NCT Number	NCT07393672
Lead Sponsor	Washington State University Collaborators: Terra Mater Botanicals Pty Ltd
Conditions	Menopause, Perimenopause
Enrollment	104 participants
Start Date	2026-02-11
Primary Completion	2026-11-10 (estimated)
Study Completion	2026-11-10 (estimated)
Updated on ClinicalTrials.gov	2026-03-10